恒指收升151点，四连升累涨850点

Group 1: Market Overview - The Hang Seng Index rose by 151 points, marking its fourth consecutive increase, totaling a gain of 850 points or 3.25% [3][4] - The total market turnover was 340.39 billion, with a net inflow of 2.864 billion from northbound trading [3] - Among the 89 blue-chip stocks, 49 rose while 35 fell, indicating a mixed performance in the market [3] Group 2: Company News - 康龙化成 (CanSino Biologics) announced a placement of 58.44 million new H shares at a price of 22.82 HKD per share, raising approximately 1.334 billion HKD, with 70% of the proceeds allocated for project development [10] - 药明合联 (WuXi AppTec) proposed a cash offer of 4 HKD per share to acquire 东曜制药 (Easton Pharmaceuticals), representing a 60% premium over the last trading price [11] - 中信证券 (CITIC Securities) reported a 38.46% increase in net profit for the fiscal year 2025, reaching 30.051 billion RMB, driven by active market conditions and growth in brokerage and investment banking revenues [12] Group 3: Economic Insights - The Federal Reserve's Beige Book indicated that economic activity in most regions of the U.S. is increasing, with stable employment numbers and moderate price increases [7] - A survey revealed that 32.4% of South Korean companies in South China expect to downsize or withdraw from the market within five years, primarily due to increased competition and rising production costs [8] - The University of Hong Kong's economic policy green paper highlighted new opportunities for Hong Kong's economy, focusing on trade financing, AI, and green finance [9]